Same-day antibiotic susceptibility insights for time-critical clinical decisions.
epsilonDx is developing rapid phenotypic diagnostics to help clinical teams identify effective antibiotic options earlier and support responsible antibiotic use.
Why faster antibiotic decisions matter
In serious infections, every hour can matter. Clinical teams often need to start treatment before full susceptibility information is available. epsilonDx is working to shorten that gap by generating phenotypic insights in a clinically relevant timeframe, with the goal of supporting earlier, more informed therapy decisions.
Antibiotic Susceptibility Testing in 6-13h
Antibiotic Resistances
Walesch, S., Birkelbach, J., Jézéquel, G. et al. Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials. EMBO Rep 24, EMBR202256033 (2023). https://doi.org/10.15252/embr.202256033